Successful control of epidemic diphtheria in the states of the former union of soviet socialist republics: Lessons learned

被引:99
作者
Dittmann, S
Wharton, M
Vitek, C
Ciotti, M
Galazka, A
Guichard, S
Hardy, I
Kartoglu, U
Koyama, S
Kreysler, J
Martin, B
Mercer, D
Ronne, T
Roure, C
Steinglass, R
Strebel, P
Sutter, R
Trostle, M
机构
[1] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark
[2] Statens Serum Inst, DK-2300 Copenhagen, Denmark
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
[4] WHO, CH-1211 Geneva, Switzerland
[5] Int Federat Red Cross & Red Crescent Soc, Geneva, Switzerland
[6] UN Childrens Fund UNICEF, Geneva, Switzerland
[7] UNICEF, Alma Ata, Kazakhstan
[8] Minist Foreign Affairs, NIS Assistance Div, Tokyo, Japan
[9] Program Appropriate Technol Hlth, Seattle, WA USA
[10] Basic Support Institutionalizing Child Survival, Arlington, VA USA
[11] US Agcy Int Dev, Washington, DC 20523 USA
关键词
D O I
10.1086/315534
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epidemic diphtheria reemerged in the Russian Federation in 1990 and spread to all Newly Independent States (NIS) and Baltic States by the end of 1994. Factors contributing to the epidemic included increased susceptibility of both children and adults, socioeconomic instability, population movement, deteriorating health infrastructure, initial shortages of vaccine, and delays in implementing control measures. In 1995, aggressive control strategies were implemented, and since then, all affected countries have reported decreases of diphtheria; however, continued efforts by national health authorities and international assistance are still needed. The legacy of this epidemic includes a reexamination of the global diphtheria control strategy, new laboratory techniques for diphtheria diagnosis and analysis, and a model for future public health emergencies in the successful collaboration of multiple international partners. The reemergence of diphtheria warns of an immediate threat of other epidemics in the NIS and Baltic States and a longer-term potential for the reemergence of vaccine-preventable diseases elsewhere. Continued investment in improved vaccines, control strategies, training, and laboratory techniques is needed.
引用
收藏
页码:S10 / S22
页数:13
相关论文
共 56 条
  • [1] [Anonymous], 1997, Wkly Epidemiol Rec, V72, P128
  • [2] Epidemic investigation of diphtheria in the Republic of Armenia, 1990-1996
    Balasanian, M
    McNabb, SJN
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S69 - S72
  • [3] BEGG N, 1994, 038B ICP EPI WHO
  • [4] Diphtheria toxoid vaccine effectiveness: A case-control study in Russia
    Bisgard, KM
    Rhodes, P
    Hardy, IRB
    Litkina, IL
    Filatov, NN
    Monisov, AA
    Wharton, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S184 - S187
  • [5] Ukraine, 1992: First assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the former Soviet Union
    Chen, RT
    Hardy, IRB
    Rhodes, PH
    Tyshchenko, DK
    Moiseeva, AV
    Marievsky, VE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S178 - S183
  • [6] DITTMANN S, 1994, 038A ICP EPI WHO
  • [7] DOULL JAMES A., 1930, JOUR PREVENT MED, V4, P371
  • [8] The European Laboratory Working Group on Diphtheria: A global microbiologic network
    Efstratiou, A
    Roure, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S146 - S151
  • [9] Efstratiou A., 1996, Reviews in Medical Microbiology, V7, P31
  • [10] EFSTRATIOU A, 1994, 038C ICP EPI WHO